User banner image
User avatar
  • admin

Posts

Alumis Initiates ONWARD Phase 3 Clinical Program Evaluating ESK-001, an Oral TYK2 Inhibitor, in Moderate-to-Severe Plaque Psoriasis

– Co-primary endpoint of PASI 75 and sPGA 0/1 score at 24 weeks to serve as basis for U.S. regulatory submission – – Pivotal Phase...

Pan Pacific Hotels Group Extends Presence in Japan through Continued Strategic Partnership with Tokyu Hotels

THE HOTEL HIGASHIYAMA KYOTO TOKYU, A Pan Pacific Hotel, will be added to group’s portfolio in Japan from 10 January 2025 SINGAPORE, July 29, 2024...

Xuan Wu Cloud Announces Positive Profit Alert

GUANGZHOU, China, July 29, 2024 /PRNewswire/ — Xuan Wu Cloud Technology Holdings Limited (“Xuan Wu Cloud” or the “Group,” stock code: 2392.HK), a leading intelligent...

Despite External Challenges, WuXi AppTec Maintained Stable Operations in First Half of 2024; Revenue and Profit of the Second Quarter Both Steadily Improved QoQ as Expected, with Revenue Up 16.0% QoQ and Adjusted Non-IFRS Net Profit Up 28.5% QoQ

Revenue Reached RMB9,259 Million in the Second Quarter, Excluding COVID-19 Commercial Projects, Up 0.3% Year-over-Year Revenue Reached RMB17,241 Million for the First Half, Excluding COVID-19...

UNLIMEAT’s K-Vegan Products Debut at The GIANT Company

UNLIMEAT’s Plant-Based Korean Meals Across 149 GIANT and MARTIN’S Stores.   The product lineup includes plant-based meat and convenient meals like frozen kimbap products. NEW YORK,...

EXPOSURE TO WILDFIRE SMOKE GREATLY RAISES RISK OF DEMENTIA DIAGNOSIS

Key Takeaways Wildfire smoke may be particularly hazardous to brain health, according to a 10-year study of more than 1.2 million southern Californians.  Exposure to...

“Chengdu’s Exclusive Project Shines in Dubai, Setting the Standard for Global Lakeside Living”

Chengdu, July 28, 2024 (GLOBE NEWSWIRE) — Recently,  at Jumeirah Burj Al Arab Dubai’s silver-white sands on Dubai’s Persian Gulf, the Yuerong Jiuzhou project from...

Results from Anavex Life Sciences Landmark Phase IIb/III Trial of Blarcamesine Presented at Alzheimer’s Association Conference

Oral, once daily blarcamesine significantly slowed clinical decline for early Alzheimer’s disease patients with good comparative safety profile and no associated neuroimaging adverse events Clinical...

Longeveron® Presents Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ in Mild Alzheimer’s Disease at the Alzheimer’s Association International Conference® (AAIC)

– Featured Research Session oral presentation highlights findings that show Lomecel-B™ improved cognitive function, quality of life, and brain volume in the treatment of mild...

Regeneration Biomedical to Present Data on First Two Subjects in a Phase I Clinical Trial of Stem Cell Therapy delivered directly into the brains of Patients with Alzheimer’s Disease

Wnt-activated, autologous, expanded, adipose-derived stem cells administered directly into lateral ventricles of the brain via Ommaya reservoir implanted under the scalp to bypass blood brain...